SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-274508
Filing Date
2023-11-09
Accepted
2023-11-09 16:11:32
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d293097d8k.htm   iXBRL 8-K 24398
2 EX-99.1 d293097dex991.htm EX-99.1 58889
6 GRAPHIC g293097g1109225732190.jpg GRAPHIC 3175
  Complete submission text file 0001193125-23-274508.txt   222625

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA harp-20231109.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20231109_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20231109_pre.xml EX-101.PRE 11713
8 EXTRACTED XBRL INSTANCE DOCUMENT d293097d8k_htm.xml XML 3486
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 231392517
SIC: 2836 Biological Products, (No Diagnostic Substances)